Veeva Systems

Veeva Systems develops and delivers cloud-based software, AI, data, and consulting services for the life sciences industry. The company serves more than 1,500 customers, ranging from the world's largest pharmaceutical companies to emerging biotechs, covering critical operational areas from clinical development through commercial execution. Veeva operates as a Public Benefit Corporation, with a stated commitment to balancing the interests of customers, employees, shareholders, and broader communities in support of the industry's mission to improve and extend human life.

Veeva's portfolio is organized across six primary solution areas — Clinical, Regulatory, Quality, Safety, Medical, and Commercial — each designed to consolidate and streamline processes within a unified platform. The company also offers AI capabilities, including Veeva AI Agents, which are available to increase productivity and support customer-facing functions.

Clinical Solutions

• Veeva Clinical Platform brings together internal teams, clinical sites, and patients on a single platform aimed at accelerating study timelines.
• The platform is designed to facilitate collaboration between data management and clinical operations functions, which have historically been supported by separate systems.
• Veeva reports that customers have achieved 50% faster clinical study builds using its clinical solutions.
• Veeva eSource for Sites is available to eliminate paper-based processes and speed the flow of trial data.

Regulatory Solutions

• Veeva Submissions supports the authoring and management of regulatory submission content.
• Veeva Submissions Publishing handles the publishing process for regulatory dossiers.
• Veeva Submissions Archive provides long-term archiving of regulatory submissions.
• These solutions are designed to reduce rework, improve data quality, and increase visibility across regulatory operations, enabling teams to use data captured during authoring and publishing for regulatory strategy and planning.

Quality Solutions

• Veeva Quality Cloud consolidates quality processes into a single, central quality management system.
• Customer results cited include consolidating from 40 separate quality management systems down to one unified system, and closing 60% of deviations faster.

Safety Solutions

• Veeva Safety manages the intake, processing, and submission of adverse events through a single platform.
• The solution is designed to connect clinical data directly into safety databases, reducing duplicate data entry and improving process efficiency across pharmacovigilance operations.

Medical Solutions

• Veeva's medical affairs solution supports scientific relationship management, expert engagement, and content delivery.
• Veeva Link Key People provides key opinion leader (KOL) insights; customers have reported a 50% increase in customer engagement attributed to improved pre-call planning using Veeva Link data.

Commercial Solutions

• Veeva Vault CRM is the company's customer relationship management platform for commercial teams, positioned as an AI-ready foundation for sales, marketing, and medical functions.
• More than 125 customers worldwide are reported to be live on Vault CRM.
• Veeva AI and Vault CRM together are described as enabling a data-centric approach to commercial transformation.
• Veeva reports that customers have achieved 50% faster time to market for promotional content using its commercial solutions.
• 85% of new drugs approved have been launched with Veeva commercial solutions.

AI Capabilities and Recent Developments

• Veeva AI Agents are now available across the platform, targeting productivity improvements and enhanced customer centricity.
• Veeva has acquired Ostro, described as a leading brand engagement platform for life sciences, expanding its commercial capabilities.
• The company publishes industry research, including reports on how biopharma companies are applying AI to accelerate treatment adoption.

Customers and Community

• Veeva's customer base includes major pharmaceutical companies such as Boehringer Ingelheim, Daiichi Sankyo, Merck, Genentech, GSK, and BioMarin, as well as a broad range of emerging biotechs.
• The company hosts industry events including the Veeva Commercial Summit in North America, scheduled for Boston, MA in May 2026.

Veeva positions itself as a long-term strategic partner to the life sciences industry, with stated priorities around product excellence, customer success, and ongoing innovation in software, data, and AI services across the full drug development and commercialization lifecycle.